SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Pharmagreen Biotech Inc. – ‘S-1’ on 3/20/19 – ‘EX-2.4’

On:  Wednesday, 3/20/19, at 3:11pm ET   ·   Accession #:  1273511-19-18   ·   File #:  333-230413

Previous ‘S-1’:  ‘S-1’ on 6/2/08   ·   Next:  ‘S-1/A’ on 5/10/19   ·   Latest:  ‘S-1’ on 5/8/20   ·   16 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/20/19  Pharmagreen Biotech Inc.          S-1                   57:101M                                   Moroney Donna

Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML    878K 
 2: EX-2.1      Articles of Incorporation and Bylaws Dated          HTML     17K 
                November 26, 2007                                                
 3: EX-2.2      Articles of Merger Dated, October 30, 2008 (Azure   HTML     17K 
                International, Inc./ Air Transport Group Holding,                
                Inc.                                                             
 4: EX-2.3      Securities Exchange Agreement Dated April 12,       HTML     21K 
                2018, by and Among Air Trnsport Group Holdings                   
                Inc. and Wfs Pharmagreen Inc.                                    
 5: EX-2.4      Articles of Incorporation and Bylaws Dated          HTML     23K 
                December 19, 2013 for Wfs Pharmagreen Inc.                       
 6: EX-2.5      Articles of Incorporation and Bylaws Dated March    HTML     20K 
                02, 2018 for Bc1155097                                           
 7: EX-2.6      Articles of Incorporation and Bylaws Dated August   HTML     16K 
                02, 2018 for Bc1174505                                           
 8: EX-2.7      Option Agreement With Alliance Growers January 25,  HTML     18K 
                2019                                                             
 9: EX-2.8      Equity Purchase Agreement Phbi-L2 Capital           HTML     20K 
10: EX-2.9      Registration Rights Agreement Phbi-L2 Capital       HTML     18K 
11: EX-3.2      Certificate of Amendment Dated April 16, 2018       HTML     16K 
                (Authorized Increased to 9,000,000,000)                          
12: EX-3.3      Certificate of Amendment Dated May 3, 2018          HTML     16K 
13: EX-5.1      Opinion of Counsel re: Legality                     HTML     23K 
14: EX-23.1     Consent of Auditor, Dated March 14, 2019            HTML     16K 
21: R1          Document and Entity Information                     HTML     38K 
22: R2          Consolidated Balance Sheets (Unaudited)             HTML     91K 
23: R3          Consolidated Balance Sheets (Parenthetical)         HTML     30K 
24: R4          Consolidated Statements of Operations and           HTML     92K 
                Comprehensive Loss (Unaudited)                                   
25: R5          Consolidated Statement of Changes in Stockholders'  HTML     70K 
                Deficit (Unaudited)                                              
26: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML    109K 
27: R7          Nature of Business and Continuance of Operations    HTML     28K 
28: R8          Summary of Significant Accounting Policies          HTML     56K 
29: R9          Property and Equipment                              HTML     26K 
30: R10         Acquisition of WFS Pharmagreen Inc.                 HTML     26K 
31: R11         Convertible Notes                                   HTML     88K 
32: R12         Related Party Transactions                          HTML     31K 
33: R13         Common Stock                                        HTML     27K 
34: R14         Commitment                                          HTML     23K 
35: R15         Discontinued Operations                             HTML     40K 
36: R16         Income Taxes                                        HTML     32K 
37: R17         Subsequent Event                                    HTML     21K 
38: R18         Summary of Significant Accounting Policies          HTML    101K 
                (Policies)                                                       
39: R19         Property and Equipment (Tables)                     HTML     25K 
40: R20         Acquisition of WFS Pharmagreen Inc. (Tables)        HTML     22K 
41: R21         Discontinued Operations (Tables)                    HTML     43K 
42: R22         Income Taxes (Tables)                               HTML     35K 
43: R23         Nature of Business and Continuance of Operations    HTML     23K 
                (Details Narrative)                                              
44: R24         Summary of Significant Accounting Policies          HTML     21K 
                (Details Narrative)                                              
45: R25         Property and Equipment (Details)                    HTML     27K 
46: R26         Acquisition of WFS Pharmagreen Inc. (Details)       HTML     27K 
47: R27         Convertible Notes (Details Narrative)               HTML    184K 
48: R28         Related Party Transactions (Details Narrative)      HTML     32K 
49: R29         Common Stock (Details Narrative)                    HTML     40K 
50: R30         Discontinued Operations (Details)                   HTML     63K 
51: R31         Discontinued Operations (Details 2)                 HTML     62K 
52: R32         Income Taxes (Details)                              HTML     41K 
53: R33         Income Taxes (Details 2)                            HTML     32K 
54: R34         Income Taxes (Details 3)                            HTML     37K 
56: XML         IDEA XML File -- Filing Summary                      XML     81K 
55: EXCEL       IDEA Workbook of Financial Reports                  XLSX     55K 
15: EX-101.INS  XBRL Instance -- phbi-20181231                       XML    900K 
17: EX-101.CAL  XBRL Calculations -- phbi-20181231_cal               XML    123K 
18: EX-101.DEF  XBRL Definitions -- phbi-20181231_def                XML    176K 
19: EX-101.LAB  XBRL Labels -- phbi-20181231_lab                     XML    673K 
20: EX-101.PRE  XBRL Presentations -- phbi-20181231_pre              XML    414K 
16: EX-101.SCH  XBRL Schema -- phbi-20181231                         XSD    117K 
57: ZIP         XBRL Zipped Folder -- 0001273511-19-000018-xbrl      Zip     76K 


‘EX-2.4’   —   Articles of Incorporation and Bylaws Dated December 19, 2013 for Wfs Pharmagreen Inc.


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <! 
  Exhibit 2.4  
 <>   <> 

[exhibit24001.jpg][exhibit24002.jpg][exhibit24003.jpg][exhibit24004.jpg][exhibit24005.jpg][exhibit24006.jpg][exhibit24007.jpg][exhibit24008.jpg]

[exhibit24009.jpg][exhibit24010.jpg][exhibit24011.jpg][exhibit24012.jpg][exhibit24013.jpg][exhibit24014.jpg][exhibit24015.jpg][exhibit24016.jpg][exhibit24017.jpg][exhibit24018.jpg][exhibit24019.jpg][exhibit24020.jpg][exhibit24021.jpg][exhibit24022.jpg][exhibit24023.jpg][exhibit24024.jpg][exhibit24025.jpg][exhibit24026.jpg][exhibit24027.jpg][exhibit24028.jpg][exhibit24029.jpg][exhibit24030.jpg][exhibit24031.jpg][exhibit24032.jpg][exhibit24033.jpg][exhibit24034.jpg][exhibit24035.jpg][exhibit24036.jpg][exhibit24037.jpg][exhibit24038.jpg][exhibit24039.jpg][exhibit24040.jpg][exhibit24041.jpg][exhibit24042.jpg][exhibit24043.jpg][exhibit24044.jpg][exhibit24045.jpg][exhibit24046.jpg][exhibit24047.jpg][exhibit24048.jpg]



 C: 

16 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/14/23  Pharmagreen Biotech Inc.          10-Q        6/30/23   55:3.8M                                   Discount Edgar/FA
 5/19/23  Pharmagreen Biotech Inc.          10-Q        3/31/23   55:3.5M                                   Discount Edgar/FA
 2/14/23  Pharmagreen Biotech Inc.          10-Q       12/31/22   50:3.2M                                   Discount Edgar/FA
 1/17/23  Pharmagreen Biotech Inc.          10-K        9/30/22   59:5.1M                                   Discount Edgar/FA
 8/17/22  Pharmagreen Biotech Inc.          10-Q        6/30/22   48:3.7M                                   Discount Edgar/FA
 5/16/22  Pharmagreen Biotech Inc.          10-Q        3/31/22   50:3.2M                                   Discount Edgar/FA
 2/22/22  Pharmagreen Biotech Inc.          10-Q       12/31/21   50:2.8M                                   Discount Edgar/FA
12/29/21  Pharmagreen Biotech Inc.          10-K        9/30/21   62:4.9M                                   Discount Edgar/FA
 8/30/21  Pharmagreen Biotech Inc.          1-A/A                  3:1.4M                                   Discount Edgar/FA
 8/18/21  Pharmagreen Biotech Inc.          10-Q        6/30/21   48:3.6M                                   Discount Edgar/FA
 7/16/21  Pharmagreen Biotech Inc.          1-A/A                  2:1.3M                                   Discount Edgar/FA
 6/22/21  Pharmagreen Biotech Inc.          1-A/A6/22/21    6:3.8M                                   Moroney Donna
 6/20/19  SEC                               UPLOAD8/12/19    2:45K  Pharmagreen Biotech Inc.
 6/06/19  SEC                               UPLOAD8/12/19    2:44K  Pharmagreen Biotech Inc.
 5/16/19  SEC                               UPLOAD8/12/19    2:54K  Pharmagreen Biotech Inc.
 4/10/19  SEC                               UPLOAD8/12/19    2:58K  Pharmagreen Biotech Inc.
Top
Filing Submission 0001273511-19-000018   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 10:41:23.1pm ET